We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
-4.38%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
10 Year Est. Return
AUM
$129M
AUM Growth
Cap. Flow
+$136M
Cap. Flow %
105.61%
Top 10 Hldgs %
77.29%
Holding
27
New
27
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 88.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBIO icon
26
BridgeBio Pharma
BBIO
$16.4B
$19K 0.01%
+1,125
New +$47.6K
SLGCW
27
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$7K 0.01%
+2,060
New +$7.87K

Similar funds

Velan Capital Investment Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Velan Capital Investment Management, which disclosed 27 positions worth $129M. Its ten largest holdings account for 77% of the portfolio.

Its largest position is Jasper Therapeutics: 321,904 shares worth $22.9M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets.

  • Velan Capital Investment Management's largest Q4 2021 buy was Jasper Therapeutics: 321,904 shares worth $22.9M.
  • Velan Capital Investment Management's ten largest holdings make up 77% of its $129M portfolio in Q4 2021.
  • Velan Capital Investment Management disclosed 27 positions in Q4 2021, its first 13F filing on record.

Based on Velan Capital Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.